{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Benzylisoquinoline alkaloid", "Co-culture system", "Escherichia coli", "Medium", "Metabolic engineering", "Pichia pastoris", "Reticuline", "Stylopine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34663314", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "31"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "18"}], "Language": ["eng"], "ELocationID": ["200", "10.1186/s12934-021-01687-z"], "Journal": {"ISSN": "1475-2859", "JournalIssue": {"Volume": "20", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "18"}}, "Title": "Microbial cell factories", "ISOAbbreviation": "Microb Cell Fact"}, "ArticleTitle": "Establishment of a co-culture system using Escherichia coli and Pichia pastoris (Komagataella phaffii) for valuable alkaloid production.", "Pagination": {"StartPage": "200", "MedlinePgn": "200"}, "Abstract": {"AbstractText": ["Plants produce a variety of specialized metabolites, many of which are used in pharmaceutical industries as raw materials. However, certain metabolites may be produced at markedly low concentrations in plants. This problem has been overcome through metabolic engineering in recent years, and the production of valuable plant compounds using microorganisms such as Escherichia coli or yeast cells has been realized. However, the development of complicated pathways in a single cell remains challenging. Additionally, microbial cells may experience toxicity from the bioactive compounds produced or negative feedback effects exerted on their biosynthetic enzymes. Thus, co-culture systems, such as those of E. coli-E. coli and E. coli-Saccharomyces cerevisiae, have been developed, and increased production of certain compounds has been achieved. Recently, a co-culture system of Pichia pastoris (Komagataella phaffii) has gained considerable attention due to its potential utility in increased production of valuable compounds. However, its co-culture with other organisms such as E. coli, which produce important intermediates at high concentrations, has not been reported.", "Here, we present a novel co-culture platform for E. coli and P. pastoris. Upstream E. coli cells produced reticuline from a simple carbon source, and the downstream P. pastoris cells produced stylopine from reticuline. We investigated the effect of four media commonly used for growth and production of P. pastoris, and found that buffered methanol-complex medium (BMMY) was suitable for P. pastoris cells. Reticuline-producing E. coli cells also showed better growth and reticuline production in BMMY medium than that in LB medium. De novo production of the final product, stylopine from a simple carbon source, glycerol, was successful upon co-culture of both strains in BMMY medium. Further analysis of the initial inoculation ratio showed that a higher ratio of E. coli cells compared to P. pastoris cells led to higher production of stylopine.", "This is the first report of co-culture system established with engineered E. coli and P. pastoris for the de novo production of valuable compounds. The co-culture system established herein would be useful for increased production of heterologous biosynthesis of complex specialized plant metabolites."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Medicinal Cell Biology, Kobe Pharmaceutical University, Motoyamakita-machi, Higashinada-ku, Kobe, 658-8558, Japan."}], "LastName": "Urui", "ForeName": "Miya", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Medicinal Cell Biology, Kobe Pharmaceutical University, Motoyamakita-machi, Higashinada-ku, Kobe, 658-8558, Japan."}], "LastName": "Yamada", "ForeName": "Yasuyuki", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Medicinal Cell Biology, Kobe Pharmaceutical University, Motoyamakita-machi, Higashinada-ku, Kobe, 658-8558, Japan."}], "LastName": "Ikeda", "ForeName": "Yoshito", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Nonoichi-shi, Ishikawa, 921-8836, Japan."}], "LastName": "Nakagawa", "ForeName": "Akira", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Gene and Totipotency, Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, 606-8502, Japan."}, {"Identifier": [], "Affiliation": "Graduate School of Science, Osaka Prefecture University, Sakai, 599-8531, Japan."}], "LastName": "Sato", "ForeName": "Fumihiko", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Nonoichi-shi, Ishikawa, 921-8836, Japan."}], "LastName": "Minami", "ForeName": "Hiromichi", "Initials": "H"}, {"Identifier": ["0000-0001-7760-2745"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Medicinal Cell Biology, Kobe Pharmaceutical University, Motoyamakita-machi, Higashinada-ku, Kobe, 658-8558, Japan. shitan@kobepharma-u.ac.jp."}], "LastName": "Shitan", "ForeName": "Nobukazu", "Initials": "N"}], "GrantList": [{"GrantID": "17H05453", "Agency": "jsps kakenhi", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Microb Cell Fact", "NlmUniqueID": "101139812", "ISSNLinking": "1475-2859"}, "SupplMeshList": ["Komagataella phaffii"], "MeshHeadingList": [{"QualifierName": ["methods"], "DescriptorName": "Coculture Techniques"}, {"QualifierName": ["growth & development"], "DescriptorName": "Escherichia coli"}, {"QualifierName": ["methods"], "DescriptorName": "Metabolic Engineering"}, {"QualifierName": ["growth & development"], "DescriptorName": "Saccharomycetales"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Rischer H, H\u00e4kkinen ST, Ritala A, Sepp\u00e4nen-Laakso T, Miralpeix B, Capell T, et al. Plant cells as pharmaceutical factories. Curr Pharm Des. 2013;19:5640\u201360. doi: 10.2174/1381612811319310017.", "ArticleIdList": ["10.2174/1381612811319310017", "23394561"]}, {"Citation": "Cravens A, Payne J, Smolke CD. Synthetic biology strategies for microbial biosynthesis of plant natural products. Nat Commun. 2019;10:2142. doi: 10.1038/s41467-019-09848-w.", "ArticleIdList": ["10.1038/s41467-019-09848-w", "PMC6513858", "31086174"]}, {"Citation": "Yang D, Park SY, Park YS, Eun H, Lee SY. Metabolic engineering of Escherichia coli for natural product biosynthesis. Trends Biotechnol. 2020;38:745\u201365. doi: 10.1016/j.tibtech.2019.11.007.", "ArticleIdList": ["10.1016/j.tibtech.2019.11.007", "31924345"]}, {"Citation": "Nakagawa A, Matsumura E, Koyanagi T, Katayama T, Kawano N, Yoshimatsu K, et al. Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli. Nat Commun. 2016;7:10390. doi: 10.1038/ncomms10390.", "ArticleIdList": ["10.1038/ncomms10390", "PMC4748248", "26847395"]}, {"Citation": "Galanie S, Thodey K, Trenchard IJ, Filsinger Interrante M, Smolke CD. Complete biosynthesis of opioids in yeast. Science. 2015;349:1095\u2013100. doi: 10.1126/science.aac9373.", "ArticleIdList": ["10.1126/science.aac9373", "PMC4924617", "26272907"]}, {"Citation": "Srinivasan P, Smolke CD. Biosynthesis of medicinal tropane alkaloids in yeast. Nature. 2020;585:614\u20139. doi: 10.1038/s41586-020-2650-9.", "ArticleIdList": ["10.1038/s41586-020-2650-9", "PMC7529995", "32879484"]}, {"Citation": "Yuan SF, Yi X, Johnston TG, Alper HS. De novo resveratrol production through modular engineering of an Escherichia coli-Saccharomyces cerevisiae co-culture. Microb Cell Fact. 2020;19:143. doi: 10.1186/s12934-020-01401-5.", "ArticleIdList": ["10.1186/s12934-020-01401-5", "PMC7362445", "32664999"]}, {"Citation": "Croteau R, Kutchan TM, Lewis NG, Buchanan B, Gruissem W, Jones R, editors. Natural products (secondary metabolites). Biochemistry & molecular biology of plants. Maryland: American Society of Plant Physiologists; 2000. pp. 1250\u2013318."}, {"Citation": "Zhang H, Wang X. Modular co-culture engineering, a new approach for metabolic engineering. Metab Eng. 2016;37:114\u201321. doi: 10.1016/j.ymben.2016.05.007.", "ArticleIdList": ["10.1016/j.ymben.2016.05.007", "27242132"]}, {"Citation": "Jawed K, Yazdani SS, Koffas MA. Advances in the development and application of microbial consortia for metabolic engineering. Metab Eng Commun. 2019;9:e00095. doi: 10.1016/j.mec.2019.e00095.", "ArticleIdList": ["10.1016/j.mec.2019.e00095", "PMC6838517", "31720211"]}, {"Citation": "McCarty NS, Ledesma-Amaro R. Synthetic biology tools to engineer microbial communities for biotechnology. Trends Biotechnol. 2019;37:181\u201397. doi: 10.1016/j.tibtech.2018.11.002.", "ArticleIdList": ["10.1016/j.tibtech.2018.11.002", "PMC6340809", "30497870"]}, {"Citation": "Wang X, Li Z, Policarpio L, Koffas MAG, Zhang H. De novo biosynthesis of complex natural product sakuranetin using modular co-culture engineering. Appl Microbiol Biotechnol. 2020;104:4849\u201361. doi: 10.1007/s00253-020-10576-1.", "ArticleIdList": ["10.1007/s00253-020-10576-1", "32285175"]}, {"Citation": "Jones JA, Vernacchio VR, Collins SM, Shirke AN, Xiu Y, Englaender JA, et al. Complete biosynthesis of anthocyanins using E. coli Polycultures. mBio. 2017;8:e00621.", "ArticleIdList": ["PMC5461408", "28588129"]}, {"Citation": "Minami H, Kim JS, Ikezawa N, Takemura T, Katayama T, Kumagai H, et al. Microbial production of plant benzylisoquinoline alkaloids. Proc Natl Acad Sci U S A. 2008;105:7393\u20138. doi: 10.1073/pnas.0802981105.", "ArticleIdList": ["10.1073/pnas.0802981105", "PMC2396723", "18492807"]}, {"Citation": "Sgobba E, Stumpf AK, Vortmann M, Jagmann N, Krehenbrink M, Dirks-Hofmeister ME, et al. Synthetic Escherichia coli-Corynebacterium glutamicum consortia for l-lysine production from starch and sucrose. Bioresour Technol. 2018;260:302\u201310. doi: 10.1016/j.biortech.2018.03.113.", "ArticleIdList": ["10.1016/j.biortech.2018.03.113", "29631180"]}, {"Citation": "Vogl T, Hartner FS, Glieder A. New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris. Curr Opin Biotechnol. 2013;24:1094\u2013101. doi: 10.1016/j.copbio.2013.02.024.", "ArticleIdList": ["10.1016/j.copbio.2013.02.024", "PMC3841573", "23522654"]}, {"Citation": "Schwarzhans JP, Luttermann T, Geier M, Kalinowski J, Friehs K. Towards systems metabolic engineering in Pichia pastoris. Biotechnol Adv. 2017;35:681\u2013710. doi: 10.1016/j.biotechadv.2017.07.009.", "ArticleIdList": ["10.1016/j.biotechadv.2017.07.009", "28760369"]}, {"Citation": "Yang Z, Zhang Z. Engineering strategies for enhanced production of protein and bio-products in Pichia pastoris: A review. Biotechnol Adv. 2018;36:182\u201395. doi: 10.1016/j.biotechadv.2017.11.002.", "ArticleIdList": ["10.1016/j.biotechadv.2017.11.002", "29129652"]}, {"Citation": "Liu Y, Tu X, Xu Q, Bai C, Kong C, Liu Q, et al. Engineered monoculture and co-culture of methylotrophic yeast for de novo production of monacolin J and lovastatin from methanol. Metab Eng. 2018;45:189\u201399. doi: 10.1016/j.ymben.2017.12.009.", "ArticleIdList": ["10.1016/j.ymben.2017.12.009", "29258964"]}, {"Citation": "Liu XB, Liu M, Tao XY, Zhang ZX, Wang FQ, Wei DZ. Metabolic engineering of Pichia pastoris for the production of dammarenediol-II. J Biotechnol. 2015;216:47\u201355. doi: 10.1016/j.jbiotec.2015.10.005.", "ArticleIdList": ["10.1016/j.jbiotec.2015.10.005", "26467715"]}, {"Citation": "Wriessnegger T, Augustin P, Engleder M, Leitner E, M\u00fcller M, Kaluzna I, et al. Production of the sesquiterpenoid (+)-nootkatone by metabolic engineering of Pichia pastoris. Metab Eng. 2014;24:18\u201329. doi: 10.1016/j.ymben.2014.04.001.", "ArticleIdList": ["10.1016/j.ymben.2014.04.001", "24747046"]}, {"Citation": "Moser S, Strohmeier GA, Leitner E, Plocek TJ, Vanhessche K, Pichler H. Whole-cell (+)-ambrein production in the yeast Pichia pastoris. Metab Eng Commun. 2018;7:e00077. doi: 10.1016/j.mec.2018.e00077.", "ArticleIdList": ["10.1016/j.mec.2018.e00077", "PMC6127371", "30197866"]}, {"Citation": "Hori K, Okano S, Sato F. Efficient microbial production of stylopine using a Pichia pastoris expression system. Sci Rep. 2016;6:22201. doi: 10.1038/srep22201.", "ArticleIdList": ["10.1038/srep22201", "PMC4770593", "26923560"]}, {"Citation": "Minami H. Fermentative production of plant benzylisoquinoline alkaloids in microbes. Biosci Biotechnol Biochem. 2013;77:1617\u201322. doi: 10.1271/bbb.130106.", "ArticleIdList": ["10.1271/bbb.130106", "23924710"]}, {"Citation": "Diamond A, Desgagn\u00e9-Penix I. Metabolic engineering for the production of plant isoquinoline alkaloids. Plant Biotechnol J. 2016;14:1319\u201328. doi: 10.1111/pbi.12494.", "ArticleIdList": ["10.1111/pbi.12494", "26503307"]}, {"Citation": "Matsumura E, Nakagawa A, Tomabechi Y, Ikushiro S, Sakaki T, Katayama T, et al. Microbial production of novel sulphated alkaloids for drug discovery. Sci Rep. 2018;8:7980. doi: 10.1038/s41598-018-26306-7.", "ArticleIdList": ["10.1038/s41598-018-26306-7", "PMC5964154", "29789647"]}, {"Citation": "Meng Y, Shao X, Wang Y, Li Y, Zheng X, Wei G, et al. Extension of cell membrane boosting squalene production in the engineered Escherichia coli. Biotechnol Bioeng. 2020;117:3499\u2013507. doi: 10.1002/bit.27511.", "ArticleIdList": ["10.1002/bit.27511", "32691870"]}, {"Citation": "Jang SI, Kim BH, Lee WY, An SJ, Choi HG, Jeon BH, et al. Stylopine from Chelidonium majus inhibits LPS-induced inflammatory mediators in RAW 264.7 cells. Arch Pharm Res. 2004;27:923\u20139. doi: 10.1007/BF02975845.", "ArticleIdList": ["10.1007/BF02975845", "15473662"]}, {"Citation": "Okamoto T, Kawaguchi K, Watanabe S, Agustina R, Ikejima T, Ikeda K, et al. Characterization of human ATP-binding cassette protein subfamily D reconstituted into proteoliposomes. Biochem Biophys Res Commun. 2018;496:1122\u20137. doi: 10.1016/j.bbrc.2018.01.153.", "ArticleIdList": ["10.1016/j.bbrc.2018.01.153", "29397936"]}, {"Citation": "Pyne ME, Narcross L, Martin VJJ. Engineering plant secondary netabolism in microbial systems. Plant Physiol. 2019;179:844\u2013861. doi: 10.1104/pp.18.01291.", "ArticleIdList": ["10.1104/pp.18.01291", "PMC6393802", "30643013"]}, {"Citation": "Pyne ME, Kevvai K, Grewal PS, Narcross L, Choi B, Bourgeois L, et al. A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids. Nat Commun. 2020;11:3337. doi: 10.1038/s41467-020-17172-x.", "ArticleIdList": ["10.1038/s41467-020-17172-x", "PMC7335070", "32620756"]}, {"Citation": "Yamada Y, Urui M, Oki H, Inoue K, Matsui H, Ikeda Y, et al. Transport engineering for improving production and secretion of valuable alkaloids in Escherichia coli. Metab Eng Commun. 2021;13:e00184. doi: 10.1016/j.mec.2021.e00184.", "ArticleIdList": ["10.1016/j.mec.2021.e00184", "PMC8449128", "34567974"]}, {"Citation": "Dastmalchi M, Chang L, Chen R, Yu L, Chen X, Hagel JM, et al. Purine permease-type benzylisoquinoline alkaloid transporters in opium poppy. Plant Physiol. 2019;181:916\u201333. doi: 10.1104/pp.19.00565.", "ArticleIdList": ["10.1104/pp.19.00565", "PMC6836811", "31467164"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "22"}, {"Year": "2021", "Month": "9", "Day": "24"}, {"Year": "2021", "Month": "10", "Day": "19", "Hour": "5", "Minute": "38"}, {"Year": "2021", "Month": "10", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["34663314", "PMC8522034", "10.1186/s12934-021-01687-z", "10.1186/s12934-021-01687-z"]}}], "PubmedBookArticle": []}